scstocks: I went ahead and sold my position at $48.71. In at 45.33 so I picked up $3.38 a shares in less than 3 trading days. Of course the market will probably roll over dead later and cough up 30 on the S&P. but in this type of manipulated, phony market I think it's best to book your profits when you have them. Short leash until we see a clear direction. I will revisit SRTY and also FAZ and a few other short plays at the the right time. There will be big profits eventually for investors on the short side.
SC, I noticed the RSPI chart is looking somewhat interesting, with a 'truncated' look at $4 over the past month or so. I've seen that type of thing in the past prior to financing announcements, where the financing entity maintains an upper cap on the share price during the pricing period for the financing.
Not sure that's what's happening here, but the chart does look suspicious, since around mid-January. I see there was an SEC filing that announced the resignation of their CFO (Weingarten) on Feb 17. May just be a coincidence, though perhaps it might be related to a coming financing or some other event. Wouldn't it be something if there's a change of ownership coming, so Weingarten decided to preemptively bail. Just a wild guess though, from the 'conspiracy king' lol..
In the bio realm, another bottom play to watch is CLDX. The chart has basically flatlined for a full year, between 3 and 5, after having been in the 30s back in 2015. I haven't really been following them, but several articles indicate they have a fairly robust pipeline with various shots on goal, so it might be a candidate for an eventual rebound -
News 
Market Data 
Discover 
AI
